Effects of rapamycin on human HLA-unrestricted cell killing

Clinical Immunology and Immunopathology
H LuoJ Wu

Abstract

Rapamycin (RAPA) is a potent immunosuppressant and can effectively prevent allograft rejection at a dosage 10- to 100-fold lower than that of cyclosporin A. RAPA strongly inhibits proliferation and function of T and B cells. In this study, we investigated the effect of RAPA on human HLA-unrestricted cell killing. It was shown that in vitro RAPA inhibited the cytolytic effect of natural killer cells and lymphokine-activated killer cells (LAK) and inhibited antibody-dependent cell-mediated cytotoxicity. The effective concentration of RAPA was 10- to 100-fold higher than that required for inhibiting T cell proliferation. These results suggest that there could be a therapeutic dose window at which RAPA inhibits T cell activity while it leaves HLA-unrestricted cell killing unaffected. We also demonstrated that while IL4 inhibited LAK activity, and RAPA inhibited IL4-promoted T cell proliferation, RAPA was not able to antagonize IL4's inhibitory effect on LAK. This indicates that the mechanism of interaction between RAPA and IL4 on LAK is different from that on T cells.

References

Feb 1, 1991·European Journal of Immunology·B E BiererS J Burakoff
Oct 1, 1991·Immunology Today·K KärreR Kiessling
Oct 1, 1986·The Journal of Experimental Medicine·J R OrtaldoR Overton
Oct 1, 1982·Molecular Immunology·R B Herberman
Feb 1, 1981·Transplantation·M IntronaA Mantovani

❮ Previous
Next ❯

Citations

Jan 1, 1994·Medicinal Research Reviews·S N SehgalB M Weichman
Jan 15, 2008·Transplantation·Lu-En WaiSheri M Krams
Nov 24, 2007·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·J Salzmann, S Lightman
Mar 30, 2006·Transplantation·William H KitchensJoren C Madsen
Oct 10, 2001·Therapeutic Drug Monitoring·K L Napoli, P J Taylor
Nov 1, 1993·Clinical and Experimental Immunology·H LuoJ Wu
Oct 6, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jann N SarkariaJan C Buckner
Feb 1, 1997·Transplantation Proceedings·B D Kahan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.